This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Alzheimer's disease and dementia
  • /
  • Nilvadipine in mild to moderate Alzheimer disease:...

Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial.

Read time: 2 mins
Published:24th Sep 2018
Author: Lawlor B, Segurado R, Kennelly S, Olde Rikkert MGM, Howard R, Pasquier F et al.
Source: PLoS One
Availability: Free full text
Ref.:PLoS Med. 2018;15(9):e1002660.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest